Navigation Links
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Date:6/3/2008

XIAFLEX also Meets Primary Endpoint (p<0.001) in Australian CORD II Phase

III Study Pharmacokinetic Study Demonstrates Lack of Systemic Exposure of XIAFLEX Serious Adverse Events Occurring at a 0.33% Rate per XIAFLEX injection Conference call scheduled for today, June 3, at 8:45 a.m. Eastern Time

MALVERN, Pa., June 3 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced positive top-line efficacy and safety results from the CORD I and CORD II phase III clinical trials for XIAFLEX(TM) (clostridial collagenase for injection) in the treatment of Dupuytren's contracture. Each of the CORD I and II trials successfully met the primary endpoint, a reduction in the angle of a patient's joint contracture to

"We believe that this is a great day for the patients who suffer from Dupuytren's contracture, the physicians who treat the disease, and Auxilium, as XIAFLEX appears
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Eli Lilly and Company (NYSE: ... scams, purportedly using the name of the company and/or ... the public through postal mail solicitations and job-seekers through ... any foreign lottery organizations and do not conduct the ... of the scam. The activities described in these scams ...
(Date:6/19/2013)... , June 19, 2013   NextDocs announced ... service clinical research organization, at DIA 2013 , ... companies will present case studies that explore best practices ... to electronic trial master file (eTMF) systems. ... will present alongside Krystyna Kowalczyk , executive vice ...
(Date:6/19/2013)... , June 19, 2013   BioCision ... sample standardization and handling in many areas of ... of new patents by the U.S. Patent Office ... products developed to standardize sample handling to ensure ... results in common laboratory procedures. ...
Breaking Medicine Technology:Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2NextDocs and Novella to Present on eTMF at DIA 2013 2BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... 2012 Mylan Inc. (Nasdaq: MYL ) ... received final approval from the U.S. Food and Drug ... for Fluvastatin Capsules USP, 20 mg and 40 mg, ... Capsules. This product is indicated for the treatment of ...
... Maine, April 12, 2012 Expanding on the ... devices, Puritan Medical Products Co. LLC launches two ... use through its newly created division, Puritan Diagnostics ... Our universal transport media system has ...
Cached Medicine Technology:Mylan Launches First Generic Version of Lescol® Capsules 2Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems 2
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
(Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 North ... announced organizational changes to advance development of its ... said, “To support the advanced development of our ... changes to the Company’s management structure and engaged ... The Company announced that Michael Galiger will serve ...
(Date:6/19/2013)... Atlanta, Ga (PRWEB) June 19, 2013 ... billing and business management software solutions for the post-acute care ... position 79 - on the Healthcare Informatics 100 (HCI ... healthcare IT companies in the U.S. in terms of revenue ... grown at an average rate of 85% annually, and the ...
Breaking Medicine News(10 mins):Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3
... million commitment from James H. and Marilyn H. Simons ... as part of Memorial Sloan-Ketterings new Brain Tumor Center ... to achieve fundamental new insights into the molecular and ... plan to apply that knowledge to the creation of ...
... of Lifetime,s Nonpartisan Every Woman Counts Election Year, ... Issues That Matter Most -, NEW YORK, Feb. ... Heart Month, Lifetime Television launches its third annual Don,t,Skip ... the nation,s leading women,s health experts, the Network offers,a ...
... - The field of presidential contenders dwindled Wednesday when ... John Edwards (D-N.C.) dropped out of the race. ... frontrunners will continue to face a formidable challenge from ... season will intensify this weekend as the candidates visit ...
... Feb. 1 While winter,s harsh, windy weather,is often ... of lip,irritation is harder to pinpoint. In fact, several ... have been linked to dry lips. The,key is determining ... to eliminate the problem., Speaking today at the ...
... International Associates, Inc,administrator for the HealthShares(TM) Indexes, a ... Funds, today announced,that effective at the opening of ... ALOG ) will replace Ventana Medical Systems,Inc. ... Index. Ventana,s is,being acquired by Roche group based ...
... ALLEGAN, Mich., Feb. 1 The Perrigo Company,(Nasdaq: ... Board of Directors has,authorized the repurchase of $150 ... 2010 under its ongoing share repurchase program. Any,remaining ... on,February 8, 2009. Under share repurchase programs since ...
Cached Medicine News:Health News:Simons Foundation grant boosts brain tumor research 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 3Health News:Election 2008: Sleep deprivation a tough opponent for presidential candidates 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 3Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 4
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
... is an Auto Refractor/Keratometer with ... refinement. Electronic elevation, automatic alignment, ... accuracy and all the other ... Marco Automatic Refractors/Keratometer famous, make ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Medicine Products: